•
TE
TERN
Terns Pharmaceuticals, Inc. Common Stock
polygonPHARMACEUTICAL PREPARATIONS
--
Price Chart
Market Cap
3.99B
Volume
1.28M
52W High
$48.26
52W Low
$1.87
Open
$36.47
Prev Close
$36.66
Day Range
35.40 - 37.00
About Terns Pharmaceuticals, Inc. Common Stock
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.
Latest News
Terns Announces Pricing of Upsized $650 Million Public Offering
GlobeNewswire Inc.•Dec 10
Terns Highlights Additional Positive Phase 1 Clinical Data Supporting TERN-701’s Best-in-Disease Potential in Relapsed/Refractory CML at the 67th ASH Annual Meeting
GlobeNewswire Inc.•Dec 8
Terns Stock Surges 300% in One Year — What a New $43 Million Position Signals for Investors
The Motley Fool•Dec 3
This Small-Cap Stock Has a Promising GLP-1 Drug Which Could Rival Novo Nordisk and Eli Lilly's Weight-Loss Treatments
The Motley Fool•Sep 18
Missed Out on Viking Therapeutics? Buy This Weight Loss Biotech Stock Right Now.
The Motley Fool•Sep 15
Should You Invest in This Under-the-Radar Weight Loss Stock?
The Motley Fool•Sep 15
1 New Weight Loss Drug Stock to Buy Now With $1,000 and Hold for 5 Years or More
The Motley Fool•Sep 14
Terns Announces Pricing of Upsized $150.15 Million Public Offering
GlobeNewswire Inc.•Sep 11